Manuel Monreal: DOACs Show Advantages Over VKAs in DVT Patients
Manuel Monreal, Coordinator of the RIETE Registry, shared a post on X about a recent article he and his colleagues co-authored, published in The European Journal of Internal Medicine, adding:
“Among DVT patients with similar eligibility for the pivotal RCTs, DOACs were associated with lower risks of recurrent VTE and major bleeding.
But no significant reduction was observed in trial-ineligible patients (around 15 percent of the total).”
Title: Recurrent venous thromboembolism and bleeding during anticoagulation in patients with deep-vein thrombosis treated with vitamin K antagonists or direct oral anticoagulants: insights from the RIETE registry
Authors: Paolo Prandoni, Raffaele Pesavento, Franca Bilora, Benjamin Brenner, Iria Francisco, Germán Sierra-Palomares, Ángeles Fidalgo, Jana Hirmerova, Samuel Fonseca, Manuel Monreal
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 8, 2026, 15:48Maxime Dely: Guillain-Barré Syndrome – What if the Key Lies in the Plasma?
-
Sep 8, 2026, 15:34Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
-
Sep 8, 2026, 15:31Adil Yousaf: Thrombolysis Speed Matters, but Eligibility Comes First
-
Sep 8, 2026, 15:28Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World
-
Sep 8, 2026, 15:27Mohd Ashhad: How Much Does Hemoglobin Increase After 1 Unit of PRBC?
-
Sep 8, 2026, 15:27Sanish Babu: The Hematocrit–Platelet Signal in Severe Dengue
-
Sep 8, 2026, 15:26Mary Kama: Climate-Informed Early Warning Systems for Sickle Cell Anaemia
-
Sep 8, 2026, 15:23Marissa Lechuga: Digital Transformation in Healthcare for People Living With SCD
-
Sep 8, 2026, 15:21Mohammed Javad Yousefi: Iron Deficiency and Anaemia Among Adolescent Girls in Iran